OFS
Showing 26 - 50 of 52
Breast Cancer Trial (Ovarian Function Suppression + Aromatase Inhibitor, Adjuvant Chemotherapy + Ovarian Function Suppression)
Not yet recruiting
- Breast Cancer
- Ovarian Function Suppression + Aromatase Inhibitor
- Adjuvant Chemotherapy + Ovarian Function Suppression
- (no location specified)
May 19, 2023
Breast Cancer Trial (SHR-1316 at a dose 20mg/kg q3w, SHR6390 at a dose of 150mg orally, daily, SBRT)
Recruiting
- Breast Cancer
- SHR-1316 at a dose 20mg/kg q3w
- +2 more
-
Shenyang, Liaoning, ChinaShengjing Hospital of China Medical University
Sep 12, 2022
Patient Satisfaction Trial in Cairo (two pieces obturator)
Completed
- Patient Satisfaction
- two pieces obturator
-
Cairo, EgyptCairo University
Sep 22, 2021
Leuprorelin 3M in Premenopausal Hormone Receptor-positive Breast
Not yet recruiting
- Hormone Receptor-positive Breast Cancer
- AI or TAM
- (no location specified)
May 17, 2021
Advanced Breast Cancer Trial in Beijing (The combination of Dalpiciclib with physician-selected endocrine therapy, Chemotherapy
Recruiting
- Advanced Breast Cancer
- The combination of Dalpiciclib with physician-selected endocrine therapy
- Chemotherapy selected by the physician
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 22, 2023
Cow Milk Allergy Trial in Cairo (beef broth)
Recruiting
- Cow Milk Allergy
- beef broth
-
Cairo, EgyptFaculty of Medicine, Ain Shams University
Jul 6, 2023
Type 1 Diabetes Trial in Calgary (Prebiotic, Placebo)
Unknown status
- Type 1 Diabetes
- Prebiotic
- Placebo
-
Calgary, Alberta, CanadaAlberta Children's Hospital
Apr 17, 2019
Liver Cirrhosis, Kidney Failure, Acute, Kidney Replacement Trial in Mainz (Hemodialysis, ADVOS)
Recruiting
- Liver Cirrhosis
- +3 more
- Hemodialysis
- ADVOS
-
Mainz, Rheinland-Pfalz, GermanyUNIVERSITÄTSMEDIZIN der Johannes Gutenberg-Universität Mainz I.
Nov 8, 2023
MammaPrint Value for Pre-menopausal Breast Cancer Patients
Recruiting
- Breast Cancer
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 25, 2022
Preterm Birth, Tube Feeding, Swallowing Disorder Trial in Lahore (perioral sensory motor stimulation)
Recruiting
- Preterm Birth
- +3 more
- perioral sensory motor stimulation
-
Lahore, Shadman, PakistanRafia Gul
Aug 3, 2022
Mental Disorder Trial (Experimental: experimental wellbeing promotion group (Think and Cope Positively), TAU)
Not yet recruiting
- Mental Disorder
- Experimental: experimental wellbeing promotion group (Think and Cope Positively)
- TAU
- (no location specified)
Sep 21, 2023
Breast Cancer Trial in Zhengzhou (Capecitabine+endocrine therapy, Placebo+endocrine therapy)
Recruiting
- Breast Cancer
- Capecitabine+endocrine therapy
- Placebo+endocrine therapy
-
Zhengzhou, Henan, ChinaHenan cancer hospital
Nov 19, 2022
Breast Cancer Female, Hormone Receptor Positive Malignant Tumor of Breast Trial in Worldwide (Palbociclib, Endocrine therapy)
Active, not recruiting
- Breast Cancer Female
- Hormone Receptor Positive Malignant Neoplasm of Breast
- Palbociclib
- Endocrine therapy
-
Clayton, Australia
- +24 more
Jan 5, 2022
Acute-On-Chronic Liver Failure, Hepatorenal Syndrome, Acute Kidney Injury Trial in New Delhi (Terlipressin, Albumin)
Recruiting
- Acute-On-Chronic Liver Failure
- +2 more
- Terlipressin
- Albumin
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Oct 11, 2021
Early Breast Cancer Trial in Worldwide (Trastuzumab and Pertuzumab (FDC SC) and T-DM1)
Recruiting
- Early Breast Cancer
- Trastuzumab and Pertuzumab (FDC SC) and T-DM1
-
Pleven, Bulgaria
- +55 more
Jan 18, 2023
A Validation Cohort for ACLF Diagnosis and Prognosis
Completed
- Liver Failure, Acute on Chronic
- Liver Dysfunction
- Standary therapy
-
Beijing, Beijing, China
- +11 more
Oct 19, 2020
Breast Cancer Trial in Shanghai (Neoadjuvant endocrine therapy, Neoadjuvant chemo)
Terminated
- Breast Cancer
- Neoadjuvant endocrine therapy
- Neoadjuvant chemotherapy
-
Shanghai, Shanghai, ChinaRuijin Hospital
Mar 9, 2020
Combination Acthar Gel and Tacrolimus in Treatment of Steroid
Suspended
- Nephrotic Syndrome
- Acthar Gel and Tacrolimus
-
Chattanooga, TennesseeNephronet
Feb 15, 2021
Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer Trial in Algeria, Jordan, Saudi Arabia (Combination of
Not yet recruiting
- Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer
- Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole)
-
Blida, Algeria
- +6 more
Dec 28, 2021
Premature Newborn, Nurse, Physiological Measurements Trial in Malatya (Control, Massage, Sponge Bathing)
Completed
- Premature Newborn
- +2 more
- Control
- +3 more
-
Malatya, TurkeyYeliz SUNA DAĞ
Oct 26, 2020
Effect of Drugs, Safety Issues Trial in Hangzhou (Remifemin)
Completed
- Effect of Drugs
- Safety Issues
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Jul 4, 2018